Oral L-ornithine-L-aspartate for patients with overt hepatic encephalopathy treated with lactulose: A randomized, double-blinded, placebo-controlled trial

Oral L-ornithine-L-aspartate for patients with overt hepatic encephalopathy treated with lactulose: A randomized, double-blinded, placebo-controlled trial

© 2018, Medical Association of Thailand. All rights reserved. Objective: Lactulose is widely used for treating patients with hepatic encephalopathy [HE] despite of no strong evidence of its effectiveness. L-ornithine-L-aspartate [LOLA] can lower serum ammonia level and improve mental state in patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Supot Nimanong, Inchaya Sansak, Tawesak Tanwandee, Phunchai Charatcharoenwitthaya, Watcharasak Chotiyaputta, Kanokwan Boonyapisit, Siwaporn Chainuvati
Other Authors: Faculty of Medicine, Siriraj Hospital, Mahidol University
Format: Article
Published: 2019
Subjects:
Medicine
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/46766
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University

Internet

https://repository.li.mahidol.ac.th/handle/123456789/46766

Similar Items